Work

[Expedited program and utilization for anticancer drug approval in China and the United States].

Year: 2024

Type: other

Source: PubMed

DOI: 10.3760/cma.j.cn112152-20231024-00250

Authors: Q Zhu, H Y Huang, A Q Yu, X Y Meng, Y Leng, H Fang, Z W Li, Y Tang, J Li, N Li

Institutions: China Pharmaceutical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, The University of Melbourne

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402661318

Cites:

Cited by: 2

Related to: 10